Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
Go back to Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone| (NASDAQ: APVO) | Delayed: 4.21 +0.23 (5.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.98 | 52 Week High | $4.33 | |||
| Open | $4.09 | 52 Week Low | $1.80 | |||
| Day High | $4.21 | P/E | N/A | |||
| Day Low | $3.90 | EPS | $0.00 | |||
| Volume | 10,335 | |||||
